Search form



CL Mobile Menu

FDA clears Voyager contrast injector

FDA clears Voyager contrast injector

Acist Medical Systems has received FDA clearance for its Voyager Model E2000 contrast delivery system. Voyager is designed for use in conjunction with x-ray equipment to diagnose and treat vascular disease. The company plans to launch the Voyager system in early April into the U.S. endovascular market. Voyager includes an automated syringe operated by a button-operated device called AngioTouch and a touchscreen display that lets the physician tailor injections at the patient’s side.


Loading comments...

By clicking Accept, you agree to become a member of the UBM Medica Community.